Literature DB >> 16251512

RAS gene hot-spot mutations in canine neoplasias.

A Richter1, H Murua Escobar, K Günther, J T Soller, S Winkler, I Nolte, J Bullerdiek.   

Abstract

Point mutations in the cellular homologues HRAS, KRAS2, and NRAS of the viral Harvey and Kirsten rat sarcoma virus oncogenes are commonly involved in the onset of malignancies in humans and other species such as dog, mouse, and rat. Most often, three particular hot-spot codons are affected, with one amino acid exchange being sufficient for the induction of tumor growth. While RAS genes have been shown to play an important role in canine tumors such as non-small lung cell carcinomas, data about RAS mutations in canine fibrosarcomas as well as KRAS2 mutations in canine melanomas is sparse. To increase the number of tumors examined, we recently screened 13 canine fibrosarcomas and 11 canine melanomas for point mutations, particularly within the mutational hot spots. The results were compared to the already existing data from other studies about these tumors in dogs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251512     DOI: 10.1093/jhered/esi121

Source DB:  PubMed          Journal:  J Hered        ISSN: 0022-1503            Impact factor:   2.645


  8 in total

1.  6-Bromoindirubin-3'oxime (BIO) decreases proliferation and migration of canine melanoma cell lines.

Authors:  Esther Chon; Brandi Flanagan; Lucas Campos de Sá Rodrigues; Caroline Piskun; Timothy J Stein
Journal:  Vet J       Date:  2014-07-31       Impact factor: 2.688

2.  Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test.

Authors:  Brennan Decker; Heidi G Parker; Deepika Dhawan; Erika M Kwon; Eric Karlins; Brian W Davis; José A Ramos-Vara; Patty L Bonney; Elizabeth A McNiel; Deborah W Knapp; Elaine A Ostrander
Journal:  Mol Cancer Res       Date:  2015-03-12       Impact factor: 5.852

3.  The class I PI3K/Akt pathway is critical for cancer cell survival in dogs and offers an opportunity for therapeutic intervention.

Authors:  Yu-Ting Chen; Karen Al Tan; Lisa Y Pang; David J Argyle
Journal:  BMC Vet Res       Date:  2012-05-30       Impact factor: 2.741

4.  Upregulation of the PI3K/Akt pathway in the tumorigenesis of canine thyroid carcinoma.

Authors:  M Campos; M M J Kool; S Daminet; R Ducatelle; G Rutteman; H S Kooistra; S Galac; J A Mol
Journal:  J Vet Intern Med       Date:  2014-09-17       Impact factor: 3.333

Review 5.  Comparative Aspects of BRAF Mutations in Canine Cancers.

Authors:  Hiroyuki Mochizuki; Matthew Breen
Journal:  Vet Sci       Date:  2015-08-24

6.  BRAF Mutations in Canine Cancers.

Authors:  Hiroyuki Mochizuki; Katherine Kennedy; Susan G Shapiro; Matthew Breen
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

7.  Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma.

Authors:  Kim Wong; Louise van der Weyden; Courtney R Schott; Alastair Foote; Fernando Constantino-Casas; Sionagh Smith; Jane M Dobson; Elizabeth P Murchison; Hong Wu; Iwei Yeh; Douglas R Fullen; Nancy Joseph; Boris C Bastian; Rajiv M Patel; Inigo Martincorena; Carla Daniela Robles-Espinoza; Vivek Iyer; Marieke L Kuijjer; Mark J Arends; Thomas Brenn; Paul W Harms; Geoffrey A Wood; David J Adams
Journal:  Nat Commun       Date:  2019-01-21       Impact factor: 14.919

8.  Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors.

Authors:  Eleonora Zorzan; Katia Hanssens; Mery Giantin; Mauro Dacasto; Patrice Dubreuil
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.